Antiseizure medications prescribing for behavioural and psychiatric concerns in adults with an intellectual disability living in England

David Branford, James J. Sun, Rohit Shankar*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

18 Downloads (Pure)

Abstract

Antiseizure medications (ASMs) are the second most widely prescribed psychotropic for people with intellectual disabilities in England. Multiple psychotropic prescribing is prevalent in almost half of people with intellectual disabilities on ASMs. This analysis identifies limited evidence of ASM benefit in challenging behaviour management and suggests improvements needed to inform clinical practice.

Original languageEnglish
Pages (from-to)191-195
Number of pages5
JournalBritish Journal of Psychiatry
Volume222
Issue number5
DOIs
Publication statusPublished - 14 Feb 2023

ASJC Scopus subject areas

  • Psychiatry and Mental Health

Keywords

  • challenging behaviour
  • Epilepsy
  • learning disabilities
  • neurodevelopmental
  • psychiatric conditions

Fingerprint

Dive into the research topics of 'Antiseizure medications prescribing for behavioural and psychiatric concerns in adults with an intellectual disability living in England'. Together they form a unique fingerprint.

Cite this